Prokidney Corp Stock Today
| PROK Stock | USD 2.24 0.04 1.82% |
Performance11 of 100
| Odds Of DistressLess than 42
|
ProKidney Corp is selling for 2.24 as of the 8th of May 2024. This is a 1.82 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.11. ProKidney Corp has about a 42 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for ProKidney Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of March 2024 and ending today, the 8th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of July 2022 | Category Healthcare | Classification Health Care |
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina. Prokidney Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 61.62 M outstanding shares of which 11.56 M shares are at this time shorted by private and institutional investors with about 18.53 trading days to cover. More on ProKidney Corp
Moving against ProKidney Stock
| 0.8 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.78 | ILMN | Illumina Downward Rally | PairCorr |
| 0.68 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.68 | LIFE | aTyr Pharma Financial Report 14th of May 2024 | PairCorr |
| 0.6 | SHC | Sotera Health | PairCorr |
| 0.59 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.58 | TIL | Instil Bio Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
ProKidney Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ProKidney Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ProKidney Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Bruce MD | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering ProKidney Corp report their recommendations after researching ProKidney Corp's financial statements, talking to executives and customers, or listening in on ProKidney Corp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering ProKidney Corp. The ProKidney consensus assessment is calculated by taking the average forecast from all of the analysts covering ProKidney Corp. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of ProKidney Corp's profitability, liquidity, and operating efficiency, ProKidney Corp may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of ProKidney Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
ProKidney Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to ProKidney Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ProKidney Corp's financial leverage. It provides some insight into what part of ProKidney Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
ProKidney Corp (PROK) is traded on NASDAQ Exchange in USA. It is located in 2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103 and employs 163 people. ProKidney Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ProKidney Corp's market, we take the total number of its shares issued and multiply it by ProKidney Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ProKidney Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 61.62 M outstanding shares of which 11.56 M shares are at this time shorted by private and institutional investors with about 18.53 trading days to cover.
ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Check ProKidney Corp Probability Of Bankruptcy
Ownership AllocationProKidney Corp has a total of 61.62 Million outstanding shares. Over half of ProKidney Corp's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ProKidney Corp. Please watch out for any change in the institutional holdings of ProKidney Corp as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check ProKidney Ownership Details
ProKidney Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of ProKidney Corp jumping above the current price in 90 days from now is about 10.04%. The ProKidney Corp probability density function shows the probability of ProKidney Corp stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days ProKidney Corp has a beta of 0.3862 indicating as returns on the market go up, ProKidney Corp average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ProKidney Corp will be expected to be much smaller as well. Moreover, proKidney Corp has an alpha of 1.171, implying that it can generate a 1.17 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of ProKidney Corp to move above the current price in 90 days from now is about 10.04 (This ProKidney Corp probability density function shows the probability of ProKidney Stock to fall within a particular range of prices over 90 days) .
ProKidney Stock Institutional Holders
Institutional Holdings refers to the ownership stake in ProKidney Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ProKidney Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ProKidney Corp's value.| Instituion | Recorded On | Shares | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 255.1 K | |
| Squarepoint Ops Llc | 2023-12-31 | 207.7 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 135.8 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 128 K | |
| Renaissance Technologies Corp | 2023-12-31 | 120 K | |
| Federated Hermes Inc | 2023-12-31 | 113.3 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 75.3 K | |
| Xtx Topco Ltd | 2023-12-31 | 73 K | |
| Amundi | 2023-12-31 | 71.8 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 11.2 M | |
| Suvretta Capital Management, Llc | 2023-12-31 | 3.9 M |
ProKidney Corp Historical Income Statement
ProKidney Corp Income Statement is one of the three primary financial statements used for reporting ProKidney's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ProKidney Corp revenue and expense. ProKidney Corp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, ProKidney Corp's Interest Income is quite stable compared to the past year. View More FundamentalsProKidney Stock Against Markets
Picking the right benchmark for ProKidney Corp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ProKidney Corp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ProKidney Corp is critical whether you are bullish or bearish towards ProKidney Corp at a given time. Please also check how ProKidney Corp's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ProKidney Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
ProKidney Corp Corporate Management
Elected by the shareholders, the ProKidney Corp's board of directors comprises two types of representatives: ProKidney Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProKidney. The board's role is to monitor ProKidney Corp's management team and ensure that shareholders' interests are well served. ProKidney Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProKidney Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Aparna MD | VP Development | Profile | |
| Joseph MD | VP Devel | Profile | |
| Ashley Johns | VP Operations | Profile | |
| James CPA | Chief Officer | Profile | |
| Richard Williams | Senior Technology | Profile | |
| Kerry MD | VP Affairs | Profile |
How to buy ProKidney Stock?
Before investing in ProKidney Corp, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ProKidney Corp. To buy ProKidney Corp stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ProKidney Corp. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ProKidney Corp stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located ProKidney Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased ProKidney Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as ProKidney Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy ProKidney Stock please use our How to Invest in ProKidney Corp guide.
Already Invested in ProKidney Corp?
The danger of trading ProKidney Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ProKidney Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ProKidney Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ProKidney Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for ProKidney Stock analysis
When running ProKidney Corp's price analysis, check to measure ProKidney Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProKidney Corp is operating at the current time. Most of ProKidney Corp's value examination focuses on studying past and present price action to predict the probability of ProKidney Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProKidney Corp's price. Additionally, you may evaluate how the addition of ProKidney Corp to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is ProKidney Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.